UBS analyst Jon Windham downgrades Republic Services (NYSE:RSG) from Buy to Neutral.
Cellectar Biosciences Announces Up To ~$103M Private Placement Financing With Certain Institutional Investors
Transaction led by existing investor Rosalind with participation from other new and existing healthcare-focused institutional investors
Pivotal topline data in Waldenstrom's macroglobulinemia expected